Position in JNJ
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$822,862
+$76,832 QoQ
Shares Held
3,240
+6.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#3,198
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Traynor Capital Management, Inc. holds $88,098,662 across 9 Drug Manufacturers - General names. JNJ ranks #5 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
54,814 | $65,745,561 | |
| 2 | NVO |
Novo Nordisk A S
|
247,912 | $11,884,901 | |
| 3 | ABBV |
AbbVie Inc.
|
19,460 | $4,896,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,894 | $2,813,379 | |
| 5 | JNJ |
Johnson & Johnson
This page
|
3,240 | $822,862 | |
| 6 | NVS |
Novartis AG
|
5,144 | $806,167 | |
| 7 | PFE |
Pfizer Inc
|
19,204 | $462,432 | |
| 8 | AMGN |
Amgen Inc
|
960 | $347,635 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $822,862 | 3,240 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $746,030 | 3,052 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $664,309 | 3,210 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $541,055 | 2,918 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $453,056 | 2,966 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $549,593 | 3,314 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $523,379 | 3,619 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $719,870 | 4,442 | Shares | Sole | 2024-10-25 | |
| 2024-06-30 | $681,251 | 4,661 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,748,315 | 11,052 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,889,657 | 12,056 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $1,918,684 | 12,319 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $2,165,994 | 13,086 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $2,560,755 | 16,521 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,641,109 | 20,612 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $4,404,512 | 26,962 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,881,169 | 27,498 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $5,393,108 | 30,430 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $5,358,254 | 31,322 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $5,190,287 | 32,138 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $5,145,324 | 31,233 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $4,898,780 | 29,807 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $4,141,297 | 26,314 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $3,962,292 | 26,614 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,560,470 | 25,318 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $2,643,711 | 20,161 | Shares | Sole | 2020-04-29 | |
| No filing history on record for this holder in this stock. | ||||||